Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2012 7
2013 4
2014 11
2015 4
2016 6
2017 5
2018 4
2019 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
ADAR1 affects HCV infection by modulating innate immune response.
Pujantell M, Franco S, Galván-Femenía I, Badia R, Castellví M, Garcia-Vidal E, Clotet B, de Cid R, Tural C, Martínez MA, Riveira-Muñoz E, Esté JA, Ballana E. Pujantell M, et al. Among authors: badia r. Antiviral Res. 2018 Aug;156:116-127. doi: 10.1016/j.antiviral.2018.05.012. Epub 2018 Jun 12. Antiviral Res. 2018. PMID: 29906476
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Badia R, Ballana E, Castellví M, García-Vidal E, Pujantell M, Clotet B, Prado JG, Puig J, Martínez MA, Riveira-Muñoz E, Esté JA. Badia R, et al. Nat Commun. 2018 Jul 16;9(1):2739. doi: 10.1038/s41467-018-05157-w. Nat Commun. 2018. PMID: 30013105 Free PMC article.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Pujantell M, Riveira-Muñoz E, Badia R, Castellví M, Garcia-Vidal E, Sirera G, Puig T, Ramirez C, Clotet B, Esté JA, Ballana E. Pujantell M, et al. Among authors: badia r. Sci Rep. 2017 Oct 17;7(1):13339. doi: 10.1038/s41598-017-13580-0. Sci Rep. 2017. PMID: 29042669 Free PMC article.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.
Brai A, Fazi R, Tintori C, Zamperini C, Bugli F, Sanguinetti M, Stigliano E, Esté J, Badia R, Franco S, Martinez MA, Martinez JP, Meyerhans A, Saladini F, Zazzi M, Garbelli A, Maga G, Botta M. Brai A, et al. Among authors: badia r. Proc Natl Acad Sci U S A. 2016 May 10;113(19):5388-93. doi: 10.1073/pnas.1522987113. Epub 2016 Apr 26. Proc Natl Acad Sci U S A. 2016. PMID: 27118832 Free PMC article.
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection.
Garcia-Vidal E, Badia R, Pujantell M, Castellví M, Felip E, Clotet B, Riveira-Muñoz E, Ballana E, Esté JA. Garcia-Vidal E, et al. Among authors: badia r. Antiviral Res. 2019 Aug;168:18-27. doi: 10.1016/j.antiviral.2019.05.003. Epub 2019 May 8. Antiviral Res. 2019. PMID: 31077767
ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals.
Pujantell M, Badia R, Galván-Femenía I, Garcia-Vidal E, de Cid R, Alcalde C, Tarrats A, Piñol M, Garcia F, Chamorro AM, Revollo B, Videla S, Parés D, Corral J, Tural C, Sirera G, Esté JA, Ballana E, Riveira-Muñoz E. Pujantell M, et al. Among authors: badia r. Sci Rep. 2019 Dec 27;9(1):19848. doi: 10.1038/s41598-019-56422-x. Sci Rep. 2019. PMID: 31882741 Free PMC article.
Antiviral treatment strategies based on gene silencing and genome editing.
Badia R, Ballana E, Esté JA, Riveira-Muñoz E. Badia R, et al. Curr Opin Virol. 2017 Jun;24:46-54. doi: 10.1016/j.coviro.2017.04.001. Epub 2017 Apr 21. Curr Opin Virol. 2017. PMID: 28437703 Review.
Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-ones.
Nawrozkij MB, Forgione M, Yablokov AS, Lucidi A, Tomaselli D, Patsilinakos A, Panella C, Hailu GS, Kirillov IA, Badia R, Riveira-Muñoz E, Crespan E, Armijos Rivera JI, Cirilli R, Ragno R, Esté JA, Maga G, Mai A, Rotili D. Nawrozkij MB, et al. Among authors: badia r. J Med Chem. 2019 Jan 24;62(2):604-621. doi: 10.1021/acs.jmedchem.8b01238. Epub 2018 Dec 20. J Med Chem. 2019. PMID: 30525601
p21 regulates the HIV-1 restriction factor SAMHD1.
Pauls E, Ruiz A, Riveira-Muñoz E, Permanyer M, Badia R, Clotet B, Keppler OT, Ballana E, Este JA. Pauls E, et al. Among authors: badia r. Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):E1322-4. doi: 10.1073/pnas.1322059111. Epub 2014 Mar 7. Proc Natl Acad Sci U S A. 2014. PMID: 24610778 Free PMC article. No abstract available.
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors.
Camarasa M, Puig de la Bellacasa R, González ÀL, Ondoño R, Estrada R, Franco S, Badia R, Esté J, Martínez MÁ, Teixidó J, Clotet B, Borrell JI. Camarasa M, et al. Among authors: badia r. Eur J Med Chem. 2016 Jun 10;115:463-83. doi: 10.1016/j.ejmech.2016.03.055. Epub 2016 Mar 21. Eur J Med Chem. 2016. PMID: 27054294
44 results
Jump to page
Feedback